UniProt ID | ZKSC1_HUMAN | |
---|---|---|
UniProt AC | P17029 | |
Protein Name | Zinc finger protein with KRAB and SCAN domains 1 | |
Gene Name | ZKSCAN1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 563 | |
Subcellular Localization | Nucleus . | |
Protein Description | May be involved in transcriptional regulation.. | |
Protein Sequence | MMTAESREATGLSPQAAQEKDGIVIVKVEEEDEEDHMWGQDSTLQDTPPPDPEIFRQRFRRFCYQNTFGPREALSRLKELCHQWLRPEINTKEQILELLVLEQFLSILPKELQVWLQEYRPDSGEEAVTLLEDLELDLSGQQVPGQVHGPEMLARGMVPLDPVQESSSFDLHHEATQSHFKHSSRKPRLLQSRALPAAHIPAPPHEGSPRDQAMASALFTADSQAMVKIEDMAVSLILEEWGCQNLARRNLSRDNRQENYGSAFPQGGENRNENEESTSKAETSEDSASRGETTGRSQKEFGEKRDQEGKTGERQQKNPEEKTRKEKRDSGPAIGKDKKTITGERGPREKGKGLGRSFSLSSNFTTPEEVPTGTKSHRCDECGKCFTRSSSLIRHKIIHTGEKPYECSECGKAFSLNSNLVLHQRIHTGEKPHECNECGKAFSHSSNLILHQRIHSGEKPYECNECGKAFSQSSDLTKHQRIHTGEKPYECSECGKAFNRNSYLILHRRIHTREKPYKCTKCGKAFTRSSTLTLHHRIHARERASEYSPASLDAFGAFLKSCV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MMTAESREATGLS --CCCHHHHHHHCCC | 32.72 | - | |
10 | Phosphorylation | TAESREATGLSPQAA CHHHHHHHCCCHHHH | 33.62 | 30266825 | |
13 | Phosphorylation | SREATGLSPQAAQEK HHHHHCCCHHHHHHC | 19.13 | 29255136 | |
20 | Ubiquitination | SPQAAQEKDGIVIVK CHHHHHHCCCEEEEE | 49.53 | - | |
27 | Sumoylation | KDGIVIVKVEEEDEE CCCEEEEECCCCCCC | 32.57 | 28112733 | |
42 | Phosphorylation | DHMWGQDSTLQDTPP CCCCCCCCCCCCCCC | 24.11 | 27732954 | |
43 | Phosphorylation | HMWGQDSTLQDTPPP CCCCCCCCCCCCCCC | 36.41 | 27732954 | |
47 | Phosphorylation | QDSTLQDTPPPDPEI CCCCCCCCCCCCHHH | 25.41 | 30576142 | |
166 | Phosphorylation | PLDPVQESSSFDLHH ECCCCCCCCCCCCCC | 17.75 | 28348404 | |
167 | Phosphorylation | LDPVQESSSFDLHHE CCCCCCCCCCCCCCH | 33.98 | 28348404 | |
168 | Phosphorylation | DPVQESSSFDLHHEA CCCCCCCCCCCCCHH | 31.87 | 28348404 | |
178 | Phosphorylation | LHHEATQSHFKHSSR CCCHHHHHHHCCCCC | 26.91 | 28555341 | |
181 | Ubiquitination | EATQSHFKHSSRKPR HHHHHHHCCCCCCCC | 36.83 | - | |
181 | Sumoylation | EATQSHFKHSSRKPR HHHHHHHCCCCCCCC | 36.83 | 28112733 | |
184 | Phosphorylation | QSHFKHSSRKPRLLQ HHHHCCCCCCCCHHH | 44.00 | - | |
208 | Phosphorylation | PAPPHEGSPRDQAMA CCCCCCCCHHHHHHH | 17.49 | 29255136 | |
216 | Phosphorylation | PRDQAMASALFTADS HHHHHHHHHHHCCCC | 16.66 | 24247654 | |
223 | Phosphorylation | SALFTADSQAMVKIE HHHHCCCCCCCHHHH | 19.85 | - | |
228 | Sumoylation | ADSQAMVKIEDMAVS CCCCCCHHHHHHHHH | 27.56 | 28112733 | |
252 | Phosphorylation | NLARRNLSRDNRQEN HHHHCCCCCCCCHHH | 40.93 | 27251275 | |
262 | Phosphorylation | NRQENYGSAFPQGGE CCHHHCCCCCCCCCC | 19.17 | 27251275 | |
279 | Phosphorylation | NENEESTSKAETSED CCCHHHCCCCCCCHH | 38.86 | 28555341 | |
280 | Sumoylation | ENEESTSKAETSEDS CCHHHCCCCCCCHHH | 50.78 | 28112733 | |
280 | Ubiquitination | ENEESTSKAETSEDS CCHHHCCCCCCCHHH | 50.78 | 21906983 | |
280 | Sumoylation | ENEESTSKAETSEDS CCHHHCCCCCCCHHH | 50.78 | - | |
283 | Phosphorylation | ESTSKAETSEDSASR HHCCCCCCCHHHHHC | 42.13 | 25850435 | |
284 | Phosphorylation | STSKAETSEDSASRG HCCCCCCCHHHHHCC | 30.80 | 25850435 | |
287 | Phosphorylation | KAETSEDSASRGETT CCCCCHHHHHCCCCC | 24.88 | 29255136 | |
289 | Phosphorylation | ETSEDSASRGETTGR CCCHHHHHCCCCCCC | 44.78 | 29255136 | |
293 | Phosphorylation | DSASRGETTGRSQKE HHHHCCCCCCCCHHH | 37.06 | 29255136 | |
294 | Phosphorylation | SASRGETTGRSQKEF HHHCCCCCCCCHHHH | 26.71 | 29255136 | |
299 | Sumoylation | ETTGRSQKEFGEKRD CCCCCCHHHHHHHHC | 57.15 | 28112733 | |
304 | Sumoylation | SQKEFGEKRDQEGKT CHHHHHHHHCCCCCC | 62.75 | 28112733 | |
310 | Acetylation | EKRDQEGKTGERQQK HHHCCCCCCCHHHHC | 53.24 | 18586575 | |
330 | Phosphorylation | TRKEKRDSGPAIGKD HHHHHHCCCCCCCCC | 51.19 | 30576142 | |
336 | Acetylation | DSGPAIGKDKKTITG CCCCCCCCCCCCCCC | 61.33 | 25953088 | |
339 | Sumoylation | PAIGKDKKTITGERG CCCCCCCCCCCCCCC | 56.12 | 28112733 | |
339 | Sumoylation | PAIGKDKKTITGERG CCCCCCCCCCCCCCC | 56.12 | - | |
357 | Phosphorylation | KGKGLGRSFSLSSNF CCCCCCCCEECCCCC | 19.86 | 25159151 | |
359 | Phosphorylation | KGLGRSFSLSSNFTT CCCCCCEECCCCCCC | 28.70 | 25159151 | |
361 | Phosphorylation | LGRSFSLSSNFTTPE CCCCEECCCCCCCCC | 23.26 | 28348404 | |
362 | Phosphorylation | GRSFSLSSNFTTPEE CCCEECCCCCCCCCC | 41.05 | 28348404 | |
365 | Phosphorylation | FSLSSNFTTPEEVPT EECCCCCCCCCCCCC | 45.77 | 30108239 | |
366 | Phosphorylation | SLSSNFTTPEEVPTG ECCCCCCCCCCCCCC | 25.27 | 25159151 | |
372 | Phosphorylation | TTPEEVPTGTKSHRC CCCCCCCCCCCCCCC | 63.76 | 22199227 | |
374 | Phosphorylation | PEEVPTGTKSHRCDE CCCCCCCCCCCCCCC | 31.67 | 26074081 | |
375 | Ubiquitination | EEVPTGTKSHRCDEC CCCCCCCCCCCCCCC | 45.68 | - | |
375 | Sumoylation | EEVPTGTKSHRCDEC CCCCCCCCCCCCCCC | 45.68 | 28112733 | |
384 | Ubiquitination | HRCDECGKCFTRSSS CCCCCCCCCCCCCHH | 37.52 | - | |
390 | Phosphorylation | GKCFTRSSSLIRHKI CCCCCCCHHHHCCEE | 26.35 | 24719451 | |
391 | Phosphorylation | KCFTRSSSLIRHKII CCCCCCHHHHCCEEE | 29.12 | 24719451 | |
396 | Ubiquitination | SSSLIRHKIIHTGEK CHHHHCCEEEECCCC | 33.24 | - | |
400 | Phosphorylation | IRHKIIHTGEKPYEC HCCEEEECCCCCEEC | 36.31 | 29496963 | |
403 | Ubiquitination | KIIHTGEKPYECSEC EEEECCCCCEECCCC | 55.00 | - | |
405 | Phosphorylation | IHTGEKPYECSECGK EECCCCCEECCCCCC | 40.41 | - | |
408 | Phosphorylation | GEKPYECSECGKAFS CCCCEECCCCCCEEE | 24.79 | 27251275 | |
412 | Sumoylation | YECSECGKAFSLNSN EECCCCCCEEECCCC | 58.90 | 28112733 | |
412 | Sumoylation | YECSECGKAFSLNSN EECCCCCCEEECCCC | 58.90 | - | |
415 | Phosphorylation | SECGKAFSLNSNLVL CCCCCEEECCCCEEE | 31.34 | 28555341 | |
418 | Phosphorylation | GKAFSLNSNLVLHQR CCEEECCCCEEEEEE | 36.51 | 28555341 | |
428 | Phosphorylation | VLHQRIHTGEKPHEC EEEEEECCCCCCCCC | 44.67 | 27282143 | |
440 | Sumoylation | HECNECGKAFSHSSN CCCCCCHHCCCCCCC | 58.90 | 28112733 | |
443 | Phosphorylation | NECGKAFSHSSNLIL CCCHHCCCCCCCEEE | 27.59 | 23312004 | |
445 | Phosphorylation | CGKAFSHSSNLILHQ CHHCCCCCCCEEEEE | 21.52 | 23312004 | |
446 | Phosphorylation | GKAFSHSSNLILHQR HHCCCCCCCEEEEEE | 30.17 | 23312004 | |
456 | Phosphorylation | ILHQRIHSGEKPYEC EEEEECCCCCCCEEC | 46.40 | 26657352 | |
459 | Ubiquitination | QRIHSGEKPYECNEC EECCCCCCCEECCCC | 57.32 | - | |
461 | Phosphorylation | IHSGEKPYECNECGK CCCCCCCEECCCCHH | 44.15 | 23312004 | |
468 | Ubiquitination | YECNECGKAFSQSSD EECCCCHHHHHCCCC | 58.90 | - | |
471 | Phosphorylation | NECGKAFSQSSDLTK CCCHHHHHCCCCCCC | 33.73 | 17525332 | |
473 | Phosphorylation | CGKAFSQSSDLTKHQ CHHHHHCCCCCCCCC | 25.31 | 23312004 | |
478 | Sumoylation | SQSSDLTKHQRIHTG HCCCCCCCCCCCCCC | 45.07 | 28112733 | |
478 | Ubiquitination | SQSSDLTKHQRIHTG HCCCCCCCCCCCCCC | 45.07 | - | |
478 | Sumoylation | SQSSDLTKHQRIHTG HCCCCCCCCCCCCCC | 45.07 | - | |
484 | Phosphorylation | TKHQRIHTGEKPYEC CCCCCCCCCCCCCCC | 44.67 | 29496963 | |
489 | Phosphorylation | IHTGEKPYECSECGK CCCCCCCCCCCHHHH | 40.41 | - | |
492 | Phosphorylation | GEKPYECSECGKAFN CCCCCCCCHHHHCCC | 24.79 | 27251275 | |
496 | Sumoylation | YECSECGKAFNRNSY CCCCHHHHCCCCCCE | 62.56 | - | |
496 | Ubiquitination | YECSECGKAFNRNSY CCCCHHHHCCCCCCE | 62.56 | - | |
496 | Sumoylation | YECSECGKAFNRNSY CCCCHHHHCCCCCCE | 62.56 | - | |
502 | Phosphorylation | GKAFNRNSYLILHRR HHCCCCCCEEEEECC | 20.34 | 30108239 | |
503 | Phosphorylation | KAFNRNSYLILHRRI HCCCCCCEEEEECCE | 11.00 | 30108239 | |
527 | Phosphorylation | TKCGKAFTRSSTLTL CCCCCEEECCCCEEH | 34.20 | 28555341 | |
529 | Phosphorylation | CGKAFTRSSTLTLHH CCCEEECCCCEEHHH | 25.31 | 23312004 | |
530 | Phosphorylation | GKAFTRSSTLTLHHR CCEEECCCCEEHHHH | 24.93 | 28555341 | |
531 | Phosphorylation | KAFTRSSTLTLHHRI CEEECCCCEEHHHHH | 25.63 | 23312004 | |
533 | Phosphorylation | FTRSSTLTLHHRIHA EECCCCEEHHHHHHH | 24.92 | 23312004 | |
545 | Phosphorylation | IHARERASEYSPASL HHHHHHHHHCCCHHH | 43.20 | 23403867 | |
547 | Phosphorylation | ARERASEYSPASLDA HHHHHHHCCCHHHHH | 19.91 | 23403867 | |
548 | Phosphorylation | RERASEYSPASLDAF HHHHHHCCCHHHHHH | 15.22 | 28176443 | |
551 | Phosphorylation | ASEYSPASLDAFGAF HHHCCCHHHHHHHHH | 30.11 | 28176443 | |
560 | Ubiquitination | DAFGAFLKSCV---- HHHHHHHHHCC---- | 35.04 | - | |
560 | Sumoylation | DAFGAFLKSCV---- HHHHHHHHHCC---- | 35.04 | 28112733 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZKSC1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZKSC1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZKSC1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
ZSC32_HUMAN | ZSCAN32 | physical | 25416956 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13 AND SER-208, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-471, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY. |